Stay updated with breaking news from Nasdaq Grcl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gracell Biotechnologies (NASDAQ:GRCL – Get Rating) had its price objective dropped by research analysts at Piper Sandler from $25.00 to $10.00 in a research note issued on Friday, The Fly reports. Piper Sandler’s price objective would indicate a potential upside of 220.51% from the stock’s current price. A number of other research analysts have also […]
Gracell Biotechnologies (NASDAQ:GRCL – Get Rating) announced its quarterly earnings data on Monday. The company reported ($0.35) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.14), Fidelity Earnings reports. During the same quarter in the previous year, the business posted ($0.25) EPS. NASDAQ:GRCL opened at $3.43 on Tuesday. The company […]
Gracell Biotechnologies Inc. (NASDAQ:GRCL – Get Rating) – Analysts at Jefferies Financial Group increased their FY2026 earnings per share (EPS) estimates for Gracell Biotechnologies in a research note issued on Monday, May 16th. Jefferies Financial Group analyst K. Shi now forecasts that the company will earn $0.06 per share for the year, up from their […]
Gracell Biotechnologies (NASDAQ:GRCL – Get Rating) posted its quarterly earnings data on Monday. The company reported ($0.30) EPS for the quarter, topping analysts’ consensus estimates of ($0.33) by $0.03, Fidelity Earnings reports. GRCL opened at $1.83 on Tuesday. Gracell Biotechnologies has a 12 month low of $1.68 and a 12 month high of $24.58. The […]
Gracell Biotechnologies (NASDAQ:GRCL – Get Rating) had its price objective reduced by equities research analysts at Piper Sandler from $40.00 to $25.00 in a report released on Monday, The Fly reports. Separately, Zacks Investment Research lowered Gracell Biotechnologies from a “buy” rating to a “hold” rating in a research report on Wednesday, January 19th. Shares […]